Categories: News

Castellum, Inc. Congratulates John F. Campbell on Receipt of Prestigious Award

Castellum, Inc. Congratulates John F. Campbell on Receipt of Prestigious Award

Castellum, Inc. (OTC: ONOV) congratulates John F. Campbell, a member of the Company’s Advisory Board, on his recent receipt of the 2022 Doughboy Award from the National Infantry Association – https://castellumus.com/

POTOMAC, Md., Sept. 20, 2022 (GLOBE NEWSWIRE) — Castellum, Inc. (OTC: ONOV) congratulates John F. Campbell, a member of the Company’s Advisory Board, on his recent receipt of the 2022 Doughboy Award from the National Infantry Association. General Campbell joins a select list of 69 winners of the award, including Bob Hope, Gary Sinese, Ross Perot, Colin Powell, Dan Inouye, General Stanley McChrystal, and others.

“John’s extraordinary military service has been appropriately recognized with this award,” said Mark Fuller, CEO of Castellum. “We are pleased to have John as an advisor to Castellum and to call him a close friend.”

“I am humbled and honored to receive the Doughboy Award,” said John Campbell. “I look forward to continuing to serve our country while assisting Castellum in its growth plans over the coming years.”

About Castellum, Inc.:

Castellum, Inc. (OTC: ONOV) is a technology service and solutions company executing strategic acquisitions in Cyber Security, Information Technology, Information Warfare, Electronic Warfare, Systems Engineering, Software Engineering, and Software Development – https://castellumus.com/.

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning the Company’s future events or future performance. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should carefully review various risks and uncertainties identified in this release and matters disclosed at www.otcmarkets.com. These risks and uncertainties could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:
Mark Fuller, President & CEO
info@castellumus.com
301-961-4895

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/50fd40e7-a6cc-4b83-9814-e9f32028d918

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago